Carlos Paya
Vorsitzender bei VAXCYTE, INC.
Vermögen: 818 760 $ am 31.05.2024
Profil
Carlos V.
Paya is currently the Chairman at Vaxcyte, Inc. and the Executive Chairman at Highlight Therapeutics SL.
He is also a Director at Mallinckrodt Pharmaceuticals Ltd., a Venture Partner at Abingworth Management, Inc., and a Venture Partner at Ysios Capital Partners SGEIC SA. In his former positions, Dr. Paya served as the President, Chief Executive Officer & Director at Immune Design Corp.
from 2011 to 2019.
He was also the Chairman at Standard BioTools, Inc. from 2017 to 2024.
Additionally, he held the role of Independent Director at Mallinckrodt Plc from 2019 to 2022.
Prior to that, he was the President at Elan Corp.
Plc from 2008 to 2011 and the Vice President at Eli Lilly & Co. from 2001 to 2008.
He also served as the President at Elan Pharmaceuticals LLC from 2008 to 2011 and as a Professor-Medicine & Immunology at The Mayo Clinic (Old) from 1991 to 2011.
Furthermore, he held the position of Vice President at Lilly Research Laboratories from 2001 to 2008.
Dr. Paya obtained a doctorate degree from Universidad Complutense de Madrid.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXCYTE, INC.
0,01% | 06.06.2024 | 7 175 ( 0,01% ) | 504 187 $ | 31.05.2024 |
STANDARD BIOTOOLS INC.
0,03% | 14.06.2023 | 126 844 ( 0,03% ) | 314 573 $ | 31.05.2024 |
Aktive Positionen von Carlos Paya
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXCYTE, INC. | Vorsitzender | 27.10.2021 |
Highlight Therapeutics SL
 Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Vorsitzender | 17.04.2020 |
Mallinckrodt Pharmaceuticals Ltd.
 Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Direktor/Vorstandsmitglied | - |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Private Equity Investor | 01.06.2020 |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Berater | - |
Ehemalige bekannte Positionen von Carlos Paya
| Unternehmen | Position | Ende |
|---|---|---|
| STANDARD BIOTOOLS INC. | Vorsitzender | 05.01.2024 |
| MALLINCKRODT PLC | Direktor/Vorstandsmitglied | 16.06.2022 |
| IMMUNE DESIGN CORP | Vorstandsvorsitzender | 02.04.2019 |
The Mayo Clinic (Old)
 The Mayo Clinic (Old) Hospital/Nursing ManagementHealth Services Mayo Clinic provided medical care. The firm offered healthy living program, mayo clinic membership and health letter, medical products, population health and wellness programs, health plan administration, medical laboratory services and continuing education for medical professionals. The company was founded by William J. Mayo in 1919 and was headquartered in Rochester, MN. | Corporate Officer/Principal | 01.08.2011 |
| ░░░░ ░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Carlos Paya
| Universidad Complutense de Madrid | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| STANDARD BIOTOOLS INC. | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| VAXCYTE, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
The Mayo Clinic (Old)
The Mayo Clinic (Old) Hospital/Nursing ManagementHealth Services Mayo Clinic provided medical care. The firm offered healthy living program, mayo clinic membership and health letter, medical products, population health and wellness programs, health plan administration, medical laboratory services and continuing education for medical professionals. The company was founded by William J. Mayo in 1919 and was headquartered in Rochester, MN. | Health Services |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Finance |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Finance |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015. | Health Technology |
Highlight Therapeutics SL
Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Health Technology |
